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Abstract
To determine the prevalence of vascular complications among inpatients with type 2 diabe-
tes mellitus (T2DM) and factors independently associated with vascular complications in a
tertiary care department in Ningbo, China, the authors conducted a cross-sectional study
using an existing computerised medical records database. A total of 3370 adult patients with
T2DM were admitted to this tertiary care department for the first time between 2012 and
2017. Patients were categorised as those (1) with at least one vascular complication, (2)
with at least one microvascular complication, and (3) with at least one macrovascular com-
plication. Over 5 years, the prevalence of vascular, microvascular, and macrovascular com-
plications among inpatients with T2DM was 73.2%, 57.5%, and 51.4%, respectively. The
odds of vascular, microvascular, and macrovascular complications increased with age and
were higher in patients with hypertension. The odds of vascular and microvascular compli-
cations were higher in single, divorced, or widowed patients, patients with T2DM for a long
time, and patients on advanced T2DM therapeutic regimen. The odds of vascular and
macrovascular complications were lower in women. The odds of microvascular complica-
tions decreased with education. The odds of macrovascular complications were higher in
smokers. In conclusion, in the tertiary care department, more than half of inpatients with
T2DM had vascular complications, and factors independently associated with vascular com-
plications were identified. The study findings could be used in future interventional studies to
prevent and manage vascular complications among these patients.
Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder. The health, social, and eco-
nomic consequences of T2DM are enormous. Globally, China has the largest population with
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T2DM, with more than 116 million adults with T2DM, which will increase to approximately
147 million in 2045 [1]. Chronic hyperglycaemia in T2DM is related to microvascular compli-
cations (such as diabetic retinopathy, nephropathy, and neuropathy/foot), macrovascular
complications (such as coronary heart disease [CHD], stroke, and peripheral arterial disease),
poor quality of life, and even death [2,3]. In China, approximately one million deaths per year
are attributed to T2DM and its associated complications. Nearly 40% of these are premature
deaths (i.e. in adults<70 years of age) [4]. Currently, the healthcare expenditure due to T2DM
is US $63 billion, and the total economic burden of T2DM and its complications is high
[1,5,6].
Ningbo, located in the Zhejiang Province of China, is an economically developed city. With
modernisation, the city has experienced an epidemiological transition from infectious diseases
to chronic diseases [7]. In Ningbo, approximately 21% of people over the age of 40 years had
T2DM in 2015 [8]. Many patients with T2DM who received treatment at the Department of
Endocrinology and Metabolism, Ningbo First Hospital, had poor glycaemic control [9], which
could lead to vascular complications.
To date, research on vascular complications among inpatients with T2DM has not been
conducted at this tertiary care department. This study aimed to determine the prevalence of
vascular complications among these patients and factors independently associated with vascu-
lar complications. Similar studies have been conducted in other populations and settings [10–
17]. However, the evidence in this particular population and setting could be different from
others, and this needs exploration and reporting. Even if the evidence is similar, it is important
for policy and practice to replicate it. This context-specific information could be used by Chi-
nese and/or international experts to develop, evaluate, and implement interventions for pre-
venting and managing vascular complications locally and nationally. For example, UK- and
China-based experts as part of the China Health Initiative, a unique cross-country collabora-
tion between the UK and China, could use these findings to design future research studies.
Similarly, many international funding agencies (such as the Medical Research Council, UK)
funds global health research, and international experts could use these findings to design
future research studies. Thus, even small robustly conducted studies should be disseminated to
make the evidence-base strong.
Materials and methods
Study setting, design, data source, and period
The study was conducted at the Department of Endocrinology and Metabolism, Ningbo First
Hospital, China. The main responsibilities of this tertiary care hospital are to provide specialist
health and medical services and perform a larger role in health and medical research and edu-
cation [18,19]. The authors conducted a cross-sectional study using an existing computerised
medical records database that was developed for this tertiary care department by the Yinal
Software Corporation, China. As this is a medical records database, the medico-nursing team
is responsible for data entry on to the database. Another independent team of hospital staff
checks data quality and is responsible for the overall management of the database. The study
period extended from 1 July 2012 to 30 June 2017 (5 years) and included 6699 patients in the
database.
Study population and inclusion and exclusion criteria
In China, local people and people from surrounding areas can visit any hospital of their choice
without a referral from a primary care physician [18]. The study included adult patients (�18
years of age) with T2DM who were admitted to the tertiary care department for the first time.
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The management of uncontrolled blood glucose levels was the main reason for hospitalisation
of patients with T2DM. They were also tested for any new or existing vascular complication
(i.e. three microvascular complications and three macrovascular complications). These com-
plications were diagnosed by a team of qualified and experienced experts at the tertiary care
department, using national standard guidelines [20–23]. The guidelines have been developed
keeping in mind the national healthcare setting and the native Chinese population. Diabetic
retinopathy was diagnosed by ophthalmologists based on funduscopy or fundus fluorescence
findings [20]. An albumin-to-creatinine ratio�2.5 mg/mmol in men/�3.5 mg/mmol in
women or an estimated glomerular filtration rate<60 ml/min per 1.73 m2 confirmed the diag-
nosis of diabetic nephropathy [20]. The diagnosis of diabetic neuropathy was based on typical
symptoms and physical examination or nerve conduction function examination results if the
patient had no signs or symptoms [20]. The diagnosis of a diabetic foot was based on signs and
symptoms (clinical findings) and having diabetic peripheral neuropathy or peripheral arterial
stenosis [20,21]. CHD included angina or myocardial infarction with the diagnosis based on
signs and symptoms and further confirmed through coronary angiography or 320-slice spiral
computed tomography [22]. The diagnosis of stroke (ischaemic stroke) was based on signs
and symptoms and further confirmed through magnetic resonance imaging [23]. Those with
peripheral arterial disease had dull or cramping leg pain and had a plaque in the peripheral
vessel, vascular stenosis, or occlusion, as confirmed by ultrasonography [20]. Patients diag-
nosed with gestational diabetes, type 1 diabetes, secondary diabetes, unknown type of diabetes,
or endocrine disease (e.g. Cushing syndrome and hyperthyroidism) were excluded. The study
inclusion criteria were satisfied by 3370 patients.
Study variables
The following independent variables (measured at the time of the first admission to the tertiary
care department) were extracted from the database: age, sex, education, occupation, marital
status, residence (based on the “hukou” system i.e. residence registration system in China)
[24], health insurance, smoking (current status), alcohol drinking (current status), family his-
tory of T2DM (any parent or sibling), T2DM duration, blood glucose level (glycated haemo-
globin [HbA1c]; estimated using high-performance liquid chromatography [D-10
Hemoglobin Analyzer, Bio-Rad, USA]), T2DM therapeutic regimen [20], body mass index
(BMI) [25], hypertension (diagnosis based on blood pressure measurement�140/90 mm Hg
or self-reported history of hypertension and on antihypertensive therapy) [26], and hyperlipi-
daemia (diagnosis based on serum lipids: total cholesterol�4.5 mmol/L or triglycerides�1.7
mmol/L) [20]. The dependent variables extracted were vascular complications of T2DM.
Patients were categorised as those (1) with at least one vascular complication, (2) with at least
one microvascular complication, and (3) with at least one macrovascular complication. Data
on sodium-glucose co-transporter 2 inhibitors, dipeptidyl peptidase 4 inhibitors, and gluca-
gon-like peptide 1 receptor agonists were unavailable in the database. During the study period,
these drugs were not sold in this hospital because they were not approved by the China Food
and Drug Administration or not covered by the Chinese health insurance system [27].
Ethics
The Research Ethics Committee of the Ningbo First Hospital, China, approved this study. The
authors had no access to information that could identify individual participants during data
analyses. According to the research ethics rules, no informed consent was necessary.
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Statistical analyses
Numbers and percentages were calculated for categorical variables. For a normally distributed
continuous variable, the mean ± standard deviation was calculated. To find any independent
association between independent variables and vascular complications, multiple logistic
regression models were developed and independent variables with p� 0.20 in simple logistic
regressions (see S1 File) were included. The authors calculated odds ratios (ORs) and 95% con-
fidence intervals (CIs). The authors used IBM SPSS Statistics version 20.0 for Windows for
data analyses.
Results
Table 1 reports the characteristics of inpatients with T2DM with and without vascular compli-
cations. The mean ± standard deviation age of patients with T2DM was 62.9 ± 13.8 years, and
nearly 51% (n = 1713) were men. Over a period of 5 years, the prevalence of vascular, micro-
vascular, and macrovascular complications among patients with T2DM was 73.2% (n = 2466),
57.5% (n = 1939), and 51.4% (n = 1731), respectively. In total, 25.3% (n = 851), 29.7%
(n = 1000), and 33.1% (n = 1115) had diabetic retinopathy, nephropathy, and neuropathy/foot,
respectively. Similarly, 7.7% (n = 259), 10.1% (n = 342), and 44.1% (n = 1487) had CHD,
stroke, and peripheral arterial disease, respectively.
Table 2 reports the multiple logistic regression analyses—independent variables with
p� 0.20 in simple logistic regressions were included. The data below are reported as OR, 95%
CI. The odds of vascular complications increased with age (18–39 years: 1; 40–59 years: 6.54,
4.31–9.92; and�60 years: 15.98, 10.30–24.81); were higher in single, divorced, or widowed
patients than in married patients (1.48, 1.12–1.96), patients having T2DM for>10 years com-
pared to�1 year (2.75, 1.81–4.17), patients on lifestyle modification + oral antidiabetic drug
(OAD) + insulin compared to lifestyle modification alone (1.54, 1.15–2.06), and patients with
hypertension (1.50, 1.25–1.81); and were lower in women than in men (0.65, 0.54–0.79).
The odds of microvascular complications increased with age (18–39 years: 1; 40–59 years:
3.50, 2.26–5.42; and�60 years: 5.04, 3.20–7.96); decreased with education (university/college:
1; class 7–12: 1.46, 1.11–1.92; class 1–6: 1.63, 1.22–2.17; and no qualification: 1.95, 1.41–2.71);
and were higher in single, divorced, or widowed patients than in married patients (1.41, 1.12–
1.77), patients having T2DM for >5–10 years and>10 years compared to�1 year (2.22, 1.46–
3.38; and 3.70, 2.45–5.57, respectively), patients on lifestyle modification + insulin and lifestyle
modification + OAD + insulin compared to lifestyle modification alone (1.42, 1.03–1.95;
and1.57, 1.21–2.03, respectively), and patients with hypertension (1.28, 1.09–1.52).
The odds of macrovascular complications increased with age (18–39 years: 1; 40–59 years:
8.47, 4.40–16.29; and�60 years: 24.14, 12.57–46.34); were higher in smokers (1.37, 1.11–1.70)
and patients with hypertension (1.47, 1.24–1.74); and were lower in women than in men (0.71,
0.60–0.84).
Discussion
In the tertiary care department, more than half of inpatients with T2DM had vascular compli-
cations, indicating the need for interventions to prevent and manage vascular complications in
this setting and the population. Major inpatient-based studies conducted in China have
reported a relatively higher prevalence of vascular complications [10,11]. On the other hand,
major outpatient-based studies conducted in China have reported a comparatively lower prev-
alence of vascular complications [12,13]. For example, in 2007, a survey conducted in four
major Chinese cities showed the prevalence of microvascular and macrovascular complica-
tions was 34.7% and 33.4%, respectively [12]. The probable reasons behind such variations are
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Table 1. Characteristics of inpatients with T2DM with and without vascular complications.
Vascular complications Microvascular complications Macrovascular Complications
No, 904 (26.8) � Yes, 2466 (73.2) � No, 1431 (42.5) � Yes, 1939 (57.5) � No, 1639 (48.6) � Yes, 1731 (51.4) �
Age (years)
18–39 173 (84.4) 32 (15.6) 177 (86.3) 28 (13.7) 195 (95.1) 10 (4.9)
40–59 409 (39.2) 634 (60.8) 559 (53.6) 484 (46.4) 673 (64.5) 370 (35.5)
�60 322 (15.2) 1800 (84.8) 695 (32.8) 1427 (67.2) 771 (36.3) 1315 (63.7)
Sex
Male 442 (25.8) 1271 (74.2) 736 (43.0) 977 (57.0) 786 (45.9) 927 (54.1)
Female 462 (27.9) 1195 (72.1) 695 (41.9) 962 (58.1) 853 (51.5) 804 (48.5)
Education
University/college 148 (42.0) 204 (58.0) 217 (61.6) 135 (38.4) 201 (57.1) 151 (42.9)
Class 7–12 396 (30.0) 926 (70.0) 612 (46.3) 710 (53.7) 677 (51.2) 645 (48.8)
Class 1–6 254 (22.2) 890 (77.8) 426 (37.2) 718 (62.8) 510 (44.6) 634 (55.4)
No qualification 106 (19.2) 446 (80.8) 176 (31.9) 376 (68.1) 251 (45.5) 301 (54.5)
Occupation
Never worked/retired 356 (19.0) 1516 (81.0) 654 (34.9) 1218 (65.1) 780 (41.7) 1092 (58.3)
Non-manual worker 343 (44.5) 428 (55.5) 460 (59.7) 311 (40.3) 494 (64.1) 277 (35.9)
Manual worker 205 (28.2) 522 (71.8) 317 (43.6) 410 (56.4) 365 (50.2) 362 (49.8)
Marital status
Married 799 (27.6) 2096 (72.4) 1267 (43.8) 1628 (56.2) 1412 (48.8) 1483 (51.2)
Single/divorced/widowed 105 (22.1) 370 (77.9) 164 (34.5) 311 (65.5) 227 (47.8) 248 (52.2)
Residence
Urban 500 (25.2) 1488 (74.8) 837 (42.1) 1151 (57.9) 914 (46.0) 1074 (54.0)
Rural 404 (29.2) 978 (70.8) 594 (43.0) 788 (57.0) 725 (52.5) 657 (47.5)
Health insurance
Yes 727 (25.2) 2155 (74.8) 1190 (41.3) 1692 (58.7) 1350 (46.8) 1532 (53.2)
No 177 (36.3) 311 (63.7) 241 (49.4) 247 (50.6) 289 (59.2) 199 (40.8)
Smoking (current status)
No 735 (27.1) 1978 (72.9) 1132 (41.7) 1581 (58.3) 1353 (49.9) 1360 (50.1)
Yes 169 (25.7) 488 (74.3) 299 (45.5) 358 (54.5) 286 (43.5) 371 (56.5)
Alcohol drinking (current status)
No 826 (27.5) 2179 (72.5) 1286 (42.8) 1719 (57.2) 1487 (49.5) 1518 (50.5)
Yes 78 (21.4) 287 (78.6) 145 (39.7) 220 (60.3) 152 (41.6) 213 (58.4)
Family history of T2DM (any parent or
sibling)
No 578 (26.3) 1616 (73.7) 927 (42.3) 1267 (57.7) 1059 (48.3) 1135 (51.7)
Yes 326 (27.7) 850 (72.3) 504 (42.9) 672 (57.1) 580 (49.3) 596 (50.7)
T2DM duration (years)
�1 69 (49.3) 71 (50.7) 100 (71.4) 40 (28.6) 87 (62.1) 53 (37.9)
>1–5 365 (46.8) 415 (53.2) 502 (64.4) 278 (35.6) 514 (65.9) 266 (34.1)
>5–10 226 (30.3) 520 (69.7) 339 (45.4) 407 (54.6) 390 (52.3) 356 (47.7)
>10 244 (14.3) 1460 (85.7) 490 (28.8) 1214 (71.2) 648 (38.0) 1056 (62.0)
Blood glucose level (HbA1c, %)
<7% 171 (28.4) 432 (71.6) 271 (44.9) 332 (55.1) 300 (49.8) 303 (50.2)
�7% 699 (26.1) 1979 (73.9) 1112 (41.5) 1566 (58.5) 1287 (48.1) 1391 (51.9)
Unknown 34 (38.2) 55 (61.8) 48 (53.9) 41 (46.1) 52 (58.4) 37 (41.6)
T2DM therapeutic regimen
Lifestyle modificationi only 149 (40.5) 219 (59.5) 207 (56.2) 161 (43.8) 211 (57.3) 157 (42.7)
(Continued)
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different population characteristics (e.g. disease severity will determine hospital admission),
different study periods, and different case definitions used for vascular complications. Similar
studies have been conducted worldwide in a range of settings and populations. The prevalence
figures are consistent with some studies and are not consistent with others [16,28]. In terms of
ethnicity and geographical location, multi-country studies found a difference in the pattern of
vascular complications [29–31]. For example, a higher prevalence of microvascular complica-
tions and a lower prevalence of macrovascular complications were found among Chinese peo-
ple compared to Europeans [29,30]. Thus, a systematic review should be conducted to
summarise the prevalence and associated factors of vascular complications in different geo-
graphical locations.
This study findings that the odds of vascular, microvascular, and macrovascular complica-
tions increased with age and were lower in women (except in the case of microvascular com-
plications) are consistent with previous studies [28,32–36]. It has also been reported that older
and younger patients are at risk of developing a similar spectrum of vascular complications.
Men are usually at a higher risk of microvascular complications, whereas the consequences of
macrovascular complications might be greater in women. Interestingly, in the absence of
T2DM, women have a far lower risk of vascular complications for much of their lifespan.
However, the presence of T2DM confers a greater risk for vascular complications in women,
and some of the potential reasons include the contribution of sex hormones and sex-specific
risk factors [37]. Nevertheless, in this study setting and population, older men need more
attention in terms of preventing and managing their vascular complications.
The finding that the odds of microvascular complications decreased with education is con-
sistent with previous research [38–40]. Higher education levels usually help in patient
Table 1. (Continued)
Vascular complications Microvascular complications Macrovascular Complications
No, 904 (26.8) � Yes, 2466 (73.2) � No, 1431 (42.5) � Yes, 1939 (57.5) � No, 1639 (48.6) � Yes, 1731 (51.4) �
Lifestyle modificationi + OADii 250 (30.0) 584 (70.0) 401 (48.1) 433 (51.9) 412 (49.4) 422 (50.6)
Lifestyle modificationi + insuliniii 111 (27.6) 291 (72.4) 172 (42.8) 230 (57.2) 205 (51.0) 197 (49.0)
Lifestyle modificationi + OADii + insuliniii 394 (22.3) 1372 (77.7) 651 (36.9) 1115 (63.1) 811 (45.9) 955 (54.1)
BMI (kg/m2)
18.5–23.9 363 (25.0) 1087 (75.0) 589 (40.6) 861 (59.4) 687 (47.4) 763 (52.6)
<18.5 25 (18.7) 109 (81.3) 43 (32.1) 91 (67.9) 67 (50.0) 67 (50.0)
�24.0 492 (29.8) 1158 (70.2) 753 (45.6) 897 (54.4) 835 (50.6) 815 (49.4)
Unknown 24 (17.6) 112 (82.4) 46 (33.8) 90 (66.2) 50 (36.8) 86 (63.2)
Hypertension
No 398 (39.7) 605 (60.3) 537 (53.5) 466 (46.5) 619 (61.7) 384 (38.3)
Yes 506 (21.4) 1861 (78.6) 894 (37.8) 1473 (62.2) 1020 (43.1) 1347 (56.9)
Hyperlipidaemia
No 184 (22.3) 641 (77.7) 326 (39.5) 499 (60.5) 384 (46.5) 441 (53.5)
Yes 706 (28.0) 1814 (72.0) 1083 (43.0) 1437 (57.0) 1238 (49.1) 1282 (50.9)
Unknown 14 (56.0) 11 (44.0) 22 (88.0) 3 (12.0) 17 (68.0) 8 (32.0)
BMI, body mass index; HbA1c, glycated haemoglobin; OAD, oral antidiabetic drug; T2DM, type 2 diabetes mellitus.
idiet and physical activity.
iimetformin, acarbose, sulfonylureas, meglitinides, and/or thiazolidinediones.
iiilong-term insulin, intermediate insulin, rapid-acting insulin, and/or premix insulin.
�n (%).
https://doi.org/10.1371/journal.pone.0235161.t001
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Table 2. Multiple logistic regression analyses—independent variables with p� 0.20 in simple logistic regression
were included.




40–59 6.54 (4.31, 9.92)
�60 15.98 (10.30, 24.81)
Sex
Male 1
Female 0.65 (0.54, 0.79)
Occupation
Never worked/retired 1
Non-manual worker 0.81 (0.63, 1.04)
Manual worker 1.06 (0.83, 1.34)
Marital status
Married 1
Single/divorced/widowed 1.48 (1.12, 1.96)
T2DM duration (years)
�1 1
>1–5 0.91 (0.60, 1.37)
>5–10 1.47 (0.96, 2.23)
>10 2.75 (1.81, 4.17)
Blood glucose level (HbA1c, %)
<7% 1
�7% 1.13 (0.89, 1.43)
Unknown 0.61 (0.36, 1.02)
T2DM therapeutic regimen
Lifestyle modificationi only 1
Lifestyle modificationi + OADii 1.20 (0.89, 1.63)
Lifestyle modificationi + insuliniii 1.34 (0.94, 1.91)
Lifestyle modificationi + OADii + insuliniii 1.54 (1.15, 2.06)
Hypertension
No 1
Yes 1.50 (1.25, 1.81)
Hyperlipidaemia
No 1
Yes 0.91 (0.74, 1.13)




40–59 3.50 (2.26, 5.42)
�60 5.04 (3.20, 7.96)
Education
University/college 1
Class 7–12 1.46 (1.11, 1.92)
Class 1–6 1.63 (1.22, 2.17)
No qualification 1.95 (1.41, 2.71)
(Continued)
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Table 2. (Continued)
Adjusted OR (95% CI)
Occupation
Never worked/retired 1
Non-manual worker 0.81 (0.64, 1.02)
Manual worker 1.07 (0.87, 1.30)
Marital status
Married 1
Single/divorced/widowed 1.41 (1.12, 1.77)
T2DM duration (years)
�1 1
>1–5 1.16 (0.76, 1.76)
>5–10 2.22 (1.46, 3.38)
>10 3.70 (2.45, 5.57)
Blood glucose level (HbA1c, %)
<7% 1
�7% 1.11 (0.90, 1.36)
Unknown 0.67 (0.41, 1.08)
T2DM therapeutic regimen
Lifestyle modificationi only 1
Lifestyle modificationi + OADii 1.15 (0.87, 1.51)
Lifestyle modificationi + insuliniii 1.42 (1.03, 1.95)
Lifestyle modificationi + OADii + insuliniii 1.57 (1.21, 2.03)
Hypertension
No 1
Yes 1.28 (1.09, 1.52)
Hyperlipidaemia
No 1
Yes 0.98 (0.82, 1.17)




40–59 8.47 (4.40, 16.29)
�60 24.14 (12.57, 46.34)
Sex
Male 1
Female 0.71 (0.60, 0.84)
Smoking (current status)
No 1
Yes 1.37 (1.11, 1.70)
T2DM duration (in years)
�1 1
>1–5 0.76 (0.50, 1.15)
>5–10 1.07 (0.71, 1.61)
>10 1.47 (0.99, 2.20)
Blood glucose level (HbA1c, %)
<7% 1
�7% 1.14 (0.94, 1.38)
(Continued)
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education and behavioural changes [41]. The beneficial effect of education could be visible
throughout the T2DM management pathway, including access to healthcare and uptake and
adherence to health/medical advice and therapies [13,42]. The finding that the odds of vascular
and microvascular complications were higher in single, divorced, or widowed patients is also
consistent with previous research [43]. Married people usually have their spouse to look after
them, both physically and mentally, which in turn improves their access to healthcare and
uptake and adherence to health/medical advice and therapies [44,45]. In this study, the odds of
macrovascular complications were higher in smokers. Smoking is a well-researched risk factor
for CHD, stroke, and peripheral arterial disease, both in the general population and in patients
with T2DM [46,47]. Smoking cessation, as part of a healthy lifestyle, plays a major role in
reducing the risk of these diseases [46,48].
In this study, the odds of vascular and microvascular complications were higher in patients
with T2DM for>10 and>5 years, respectively. The risk of vascular complications increases
with T2DM duration [12,28,33,35,38]. The mass and function of beta-cells gradually decline
with the progression of T2DM, leading to vascular complications [49]. It should be noted that
undiagnosed T2DM is a major problem, and the exact duration of T2DM is often unknown
[50]. In a considerable number of patients, vascular complications are detected at the same
time as the diagnosis of T2DM [51,52]. The finding that the odds of vascular and microvascu-
lar complications were higher in patients on lifestyle modification + OAD + insulin as part of
their T2DM therapeutic regimen is consistent with previous research [53]. In addition, in this
study, the odds of microvascular complications were higher in patients on lifestyle modifica-
tion + insulin. A stepwise approach is recommended in the Chinese T2DM management
guideline [20]. The first step is lifestyle modification. With disease progression, OAD(s) and/
or insulin(s) are added. Therefore, the identified association is more likely to represent disease
severity and chronicity than medication effects. It should be noted that the uptake and adher-
ence to the T2DM therapeutic regimen could be different from what is prescribed [54,55].
Recently, approximately 43% of patients with T2DM in China were found to comply with
their T2DM therapeutic regimen [56]. In this study database, prescription data were available,
but uptake and adherence data were unavailable, which needs to be explored and considered
Table 2. (Continued)
Adjusted OR (95% CI)
Unknown 0.71 (0.44, 1.15)
Hypertension
No 1
Yes 1.47 (1.24, 1.74)
BMI, body mass index; CI, confidence interval; HbA1c, glycated haemoglobin; OAD, oral antidiabetic drug; OR,
odds ratio; T2DM, type 2 diabetes mellitus.
aVariables included age, sex, education, occupation, marital status, residence, health insurance, alcohol drinking,
T2DM duration, blood glucose level (HbA1c), T2DM therapeutic regimen, BMI, hypertension, and hyperlipidaemia.
bVariables included age, education, occupation, marital status, health insurance, smoking, T2DM duration, blood
glucose level (HbA1c), T2DM therapeutic regimen, BMI, hypertension, and hyperlipidaemia.
cVariables included age, sex, education, occupation, residence, health insurance, smoking, alcohol drinking, T2DM
duration, blood glucose level (HbA1c), T2DM therapeutic regimen, BMI, hypertension, and hyperlipidaemia.
idiet and physical activity.
iimetformin, acarbose, sulfonylureas, meglitinides, and/or thiazolidinediones.
iiilong-term insulin, intermediate insulin, rapid-acting insulin, and/or premix insulin.
https://doi.org/10.1371/journal.pone.0235161.t002
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in future studies. In this study, the odds of vascular, microvascular, and macrovascular compli-
cations were higher in patients with hypertension. Hypertension is a well-researched risk fac-
tor for vascular complications [28,35,38,57]. In the UK Prospective Diabetes Study, each 10
mm Hg decrease in updated mean systolic blood pressure was associated with a reduction in
risk of 12% for any vascular complication, 13% for microvascular complications, and 11% for
myocardial infarction [58]. Thus, the importance of antihypertensive therapy in patients with
hypertension cannot be ignored.
Although both microvascular and macrovascular complications are vascular diseases and
share some common risk factors, the pathophysiology and clinical manifestations differ [59].
Some of the risk factors are unique to each of these two. In this study, middle-aged and older
patients and those with hypertension had higher microvascular and macrovascular complica-
tions. In addition, those who had a lower education level, were single, divorced, or widowed, had
T2DM for a long time and were on an advanced T2DM therapeutic regimen had higher micro-
vascular complications. Similarly, men and smokers had higher macrovascular complications.
Hyperglycaemia and hyperlipidaemia are known risk factors for vascular complications
[10,11,14]. However, these associations were not significant in this study. Vascular complica-
tions develop over a period of time [12,28,33,35,38]. However, in this study, data on blood glu-
cose and serum lipids came from a single point in time and did not reflect their long-term
patterns. Postprandial blood glucose levels might be a better predictor of T2DM complica-
tions, especially macrovascular complications [60,61]. However, data on postprandial blood
glucose were of poor quality.
This study was the first to explore vascular complications among inpatients with T2DM in
a tertiary care department in Ningbo, China. As far as the authors are aware, it was the first
time an existing computerised medical records database was used for this purpose in the Zhe-
jiang Province of China. Microvascular and macrovascular complications of T2DM were
explored, which in turn provided a more complete picture. The study findings could be valid
in similar settings and populations. The authors conducted a hospital-based study, and a dif-
ferent picture could emerge from a population-based study because of differences in setting
and population. Missing data were generally low in this study. Samples with missing values for
the variables were included in the logistic regression analyses. This retrospective study used an
existing computerised medical records database; its main purpose is clinical and not research.
Therefore, data quality issues of routinely collected data could be present. In general, inpa-
tients are precisely monitored owing to disease severity, and this could have improved the data
quality. The diagnosis of CHD, stroke, and peripheral arterial disease was based on signs and
symptoms, followed by diagnostic tests. Globally, this is what is usually done in clinical prac-
tice, and the authors might have missed subclinical patients. The study findings could be due
to other factors missing in the database (e.g. uptake and adherence to the T2DM therapeutic
regimen [62]); these factors were not adjusted for in the multiple logistic regression analyses.
Recall bias could be an issue in self-reported data (e.g. family history of T2DM). This errone-
ous variable measurement could have assigned people to the wrong category, resulting in an
incorrect assessment of the relationship between family history of T2DM and vascular compli-
cations. In this cross-sectional study, it was impossible to determine the causal association
between variables and vascular complications. Thus, a long-term, longitudinal study should be
conducted to explore the effects of these and other potential factors on vascular complications.
Conclusions
In the tertiary care department in Ningbo, China, more than half of inpatients with T2DM had
vascular complications, and factors independently associated with vascular complications
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were identified. Vascular, microvascular, and macrovascular complications increased with age
and were higher in patients with hypertension. In single, divorced, or widowed patients,
patients with T2DM for a long time, and patients on advanced T2DM therapeutic regimen,
vascular and microvascular complications were found to be higher. In women, vascular and
macrovascular complications were found to be lower. Microvascular complications decreased
with education. In smokers, macrovascular complications were found to be higher.
Implications for policy and clinical practice
The context-specific information could be used to develop, evaluate, and implement interven-
tions for preventing and managing vascular complications. Overall, in clinical practice, vascu-
lar complication prevention and management strategies in the given setting and the
population need to be targeted towards middle-aged and older adults, men, smokers, those
who have a lower education level, have never worked or are retired, are single, divorced, or
widowed, have comorbidities such as hypertension, have T2DM for a long time, or are on an
advanced T2DM therapeutic regimen.
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